Literature DB >> 9642272

Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A.

Y Ono1, H Shimada, H Sorimachi, I Richard, T C Saido, J S Beckmann, S Ishiura, K Suzuki.   

Abstract

p94 (calpain3), a muscle-specific member of the calpain family, has been shown to be responsible for limb-girdle muscular dystrophy type 2A (LGMD2A), a form of autosomal recessive and progressive neuromuscular disorder. To elucidate the molecular mechanism of LGMD2A, we constructed nine p94 missense point mutants found in LGMD2A and analyzed their p94 unique properties. All mutants completely or almost completely lose the proteolytic activity against a potential substrate, fodrin. However, some of the mutants still possess autolytic activity and/or connectin/titin binding ability, indicating these properties are not necessary for the LGMD2A phenotypes. These results provide strong evidence that LGMD2A results from the loss of proteolysis of substrates by p94, suggesting a novel molecular mechanism leading to muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642272     DOI: 10.1074/jbc.273.27.17073

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium.

Authors:  S Strobl; C Fernandez-Catalan; M Braun; R Huber; H Masumoto; K Nakagawa; A Irie; H Sorimachi; G Bourenkow; H Bartunik; K Suzuki; W Bode
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.

Authors:  Junaith S Mohamed; Ameena Hajira; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

Review 3.  The role of calcium-activated protease calpain in experimental retinal pathology.

Authors:  M Azuma; T R Shearer
Journal:  Surv Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 6.048

4.  PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1.

Authors:  Yasuko Ono; Shun-Ichiro Iemura; Stefanie M Novak; Naoko Doi; Fujiko Kitamura; Tohru Natsume; Carol C Gregorio; Hiroyuki Sorimachi
Journal:  J Mol Biol       Date:  2013-05-21       Impact factor: 5.469

Review 5.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

Review 6.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

Review 7.  Homer and the ryanodine receptor.

Authors:  Pierre Pouliquin; Angela Fay Dulhunty
Journal:  Eur Biophys J       Date:  2009-06-10       Impact factor: 1.733

8.  Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Coen Ottenheijm; Henk Granzier; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2008-08-01       Impact factor: 6.150

9.  Skeletal muscle-specific calpain is an intracellular Na+-dependent protease.

Authors:  Yasuko Ono; Koichi Ojima; Fukuyo Torii; Emi Takaya; Naoko Doi; Kazuhiro Nakagawa; Shoji Hata; Keiko Abe; Hiroyuki Sorimachi
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

10.  Characterization of a new p94-like calpain form in human lymphocytes.

Authors:  Roberta De Tullio; Roberto Stifanese; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.